Ian Karp
Head of Investor Relations
Replay available
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) Q1 2026 earnings conference call, held 2026-05-07. Replay captured from the company's public earnings webcast.

Head of Investor Relations
President and Chief Executive Officer
Chief Commercial Officer
Chief Financial Officer
Analyst, HC Wainwright & Co.
Analyst, Truist Securities
Analyst, Jefferies
Analyst, Needham & Company
Watch the replay and follow the connected company analysis, news, and investor updates for Collegium Pharmaceutical, Inc..
WEBVTT 00:00:00.031 -- 00:00:04.276 Greetings, and welcome to the Collegium Pharmaceutical first quarter 2026 earnings conference 00:00:04.276 -- 00:00:08.280 call. At this time, all participants are in listen-only mode. 00:00:08.280 -- 00:00:12.044 The question and answer session will follow the formal presentation. 00:00:12.044 -- 00:00:15.668 If anyone should require operator assistance during this conference, please press star 00:00:15.668 -- 00:00:18.111 zero on your telephone keypad. 00:00:18.111 -- 00:00:20.994 Please note that this conference call is being recorded. 00:00:20.994 -- 00:00:25.479 I'll now turn the call over to Ian Karp, head of investor relations at Collegium. 00:00:25.479 -- 00:00:28.380 Thank you. You may now begin. 00:00:28.448 -- 00:00:33.655 Great, thanks so much, and welcome to Collegium Pharmaceutical's first quarter 2026 earnings 00:00:33.655 -- 00:00:37.861 conference call. I'm joined today by Vikram Karnani, our President and Chief Executive 00:00:37.861 -- 00:00:42.347 Officer, Colleen Tupper, our Chief Financial Officer, and Scott Dreyer, our Chief Commercial 00:00:42.347 -- 00:00:46.512 Officer. Before we begin today's call, we want to remind participants that none of the 00:00:46.512 -- 00:00:50.858 information presented today is intended to be promotional, and that any forward-looking 00:00:50.858 -- 00:00:55.084 statements made today are made pursuant to the Safe Harbors Provision of the Private 00:00:55.084 -- 00:00:59.809 Securities Litigation Reform Act of 1995. We are cautioned that such forward-looking 00:00:59.809 -- 00:01:04.095 statements involve risks and uncertainties, as detailed in the company's periodic reports 00:01:04.095 -- 00:01:07.038 filed with the Securities and Exchange Commission. 00:01:07.038 -- 00:01:11.8...